Picture of Anterix logo

ATEX Anterix News Story

0.000.00%
us flag iconLast trade - 00:00
TelecomsAdventurousMid CapHigh Flyer

Anterix Inc reports results for the quarter ended December 31 - Earnings Summary

* Anterix Inc  ATEX.OQ  reported quarterly adjusted earnings
of 41
cents​​ per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of 2
cents.  The mean expectation of two analysts for the quarter was
for a loss of 56 cents per share. Wall Street expected
results to range from -60 cents to -53 cents per share.
    * Revenue rose 23.2% to $1.57 million from a year ago;
analysts
expected $1.80 million. 
    * Anterix Inc's reported EPS for the quarter was 41 cents​.
    * The company reported quarterly net income of $7.71
million.
    * Anterix Inc shares had fallen by 7.0% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the wireless
telecommunications services peer group is also "buy"

Wall Street's median 12-month price target for Anterix Inc is
$87.50 
This summary was machine generated from LSEG data February 11 at
10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.56          0.41           Beat
 Sep. 30 2024      -0.59          -0.69          Missed
 Jun. 30 2024      -0.45          -0.84          Missed
 Mar. 31 2024      -0.41          -0.51          Missed

Recent news on Anterix

See all news